Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

GlyCanDrug

Financiado

Cerrado

A training network on the design of precision therapeutics that target key glyca...

A training network on the design of precision therapeutics that target key glycan motifs implicated in cancer Glycoscience has gained such significant technological advances over the past decade, that it is now poised for giving an unprecedented contribution to high-demanding societal needs. GlyCanDrug is a glycoscience-oriented DN that a... ver más

30/11/2027

UNIFI

Presupuesto desconocido

Líder del proyecto

UNIVERSITA DEGLI STUDI DI FIRENZE No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Fecha límite participación Sin fecha límite de participación.

Financiación concedida El organismo HORIZON EUROPE notifico la concesión del proyecto el día 2023-12-01

HORIZON-MSCA-2022-DN-01-01: MSCA Doctoral Networks 2022 ExpectedOutcome:Project results are expected to contribute to the following outcomes:

I+D

Cerrada hace 2 años

0% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

Participantes

UNIFI

Lider

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Proyectos interesantes

GlycoMap Integrated Glycomics for Cancer Precision Medicine 227K€ Cerrado

ROSETTA Deciphering the Role of aberrant glycOSylation in the rEspon... 176K€ Cerrado

GlycoModels 3D glyco engineered models to address the role of glycosylat... 149K€ Cerrado

CarboMed Development of carbohydrate based anticancer agents 150K€ Cerrado

GlycoTherapy New frontiers in advanced glycotherapy for cancer 2M€ Cerrado

GlycoEdit New Chemical Tools for Precision Glycotherapy 2M€ Cerrado

Duración del proyecto: 47 meses Fecha Inicio: 2023-12-01
Fecha Fin: 2027-11-30

Líder del proyecto

UNIVERSITA DEGLI STUDI DI FIRENZE No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto Glycoscience has gained such significant technological advances over the past decade, that it is now poised for giving an unprecedented contribution to high-demanding societal needs. GlyCanDrug is a glycoscience-oriented DN that aims, for the first time, to take a step ahead in the design of precision therapeutics targeting key glycan motifs implicated in cancer. These glycans are fingerprints of many cancers. Thus, their targeting has the striking potential to overcome cancer heterogeneity that limits the current targeted therapies providing new opportunities for the discovery of precision therapeutics.The credibility and high quality of GlyCanDrug are ensured by top-level glycoscientists from 9 academic institutions (8EU & 1US) and 6 SMEs which encompass complementary and intersectoral expertise, and unique state-of-the-art technological tools to train 10 doctoral candidates (DCs). GlyCanDrug focuses on the precise inhibition of the expression of cancer-associated glycans and the development of cutting-edge tools for their targeting. The unique combination of scientific excellence in interdisciplinary fields and industry know-how will cover the entire process from obtaining fundamental insights to the implementation of innovative solutions. GlyCanDrug aims at creating a critical mass of uniquely skilled graduates in glycan-based therapies. To this aim, we will equip DCs with a thorough multifaceted knowledge of the potential of glycoscience in the discovery of cancer precision therapeutics and the necessary transferable skills. This will put DCs in an advantageous position for job opportunities in both academia and industry.Deciphering the glycome expands the frontiers of knowledge and discovery and enables addressing fundamental challenges in cancer. Therefore, GlyCanDrug DN will strengthen the European innovation capacity by bringing new glycoscience concepts in the development of cancer precision therapeutics to market and policy stakeholders.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores